Clinical Trials List
2007-09-01 - 2009-11-30
Phase II
Terminated7
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chiun Hsu Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of Thoracic Medicine
- Chong-Jen Yu Division of Thoracic Medicine
- 林宗哲 Division of Hematology & Oncology
- James Chih-Hsin Yang Division of Hematology & Oncology
- JIN-YUAN SHIH Division of Thoracic Medicine
- PAN-CHYR YANG Division of Thoracic Medicine
- Ying-Chun Shen Division of Hematology & Oncology
- 陳冠宇 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Yuh-Min Chen Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Chien-Ying Liu Division of Thoracic Medicine
- 柯皓文 Division of Thoracic Medicine
- Chih-Hung Chen Division of Thoracic Medicine
- 陳豪成 Division of Thoracic Medicine
- Chih-Teng Yu Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 陳宇欽 Division of Hematology & Oncology
- 張平穎 Division of Hematology & Oncology
- Tsu-Yi Chao Division of Hematology & Oncology
- 姚乃舜 Division of Hematology & Oncology
- 高偉堯 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 陳焜結 Division of Thoracic Medicine
- TSUNG -YING YANG Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Peng-Chan Lin Division of Hematology & Oncology
- Wen-Pin Su Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 陳鴻仁 Division of Thoracic Medicine
- Chih-Yen Tu Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
0 participants
-
Global
0 participants
